[Federal Register Volume 85, Number 157 (Thursday, August 13, 2020)]
[Notices]
[Pages 49374-49375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17710]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-1054; Docket No. CDC-2020-0090]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection entitled ``Drug Overdose Response Investigation
(DORI) Data Collections.'' CDC will use the information collected to
respond to urgent requests from state and local health authorities to
provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose.
DATES: Written comments must be received on or before October 13, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0090 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the
[[Page 49375]]
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology, e.g., permitting electronic submissions of responses.
5. Assess information collection costs.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections (OMB
Control No. 0920-1054, Exp. 03/31/2018)--Revision--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received OMB approval (OMB Control No. 0920-1054) for
a new Generic clearance for a three-year period to collect information
to respond to urgent requests from state and local health authorities
to provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. CDC seeks OMB
approval for a Revision of this generic clearance for a three-year
period.
Drug Overdose Response Investigation (DORI) are to be conducted in
response to urgent requests from state and local health authorities. Of
particular interest is response to increasing trends in, or changing
characteristics of, overdose from prescription drugs (with a special
interest in opioid analgesics such as oxycodone or methadone;
benzodiazepines such as alprazolam) and/or illicit drugs (e.g.,
heroin). CDC's National Center for Injury Prevention and Control
(NCIPC) is frequently called upon to conduct DORIs at the request of
state or local health authorities seeking support to respond to urgent
public health problems resulting from drug use, misuse, addiction, and
overdose. Such requests are typically, but not always, made through the
Epi-Aid mechanism. In most investigations, CDC's epidemiological
response entails rapid and flexible collection of data that evolves
during the investigation period.
A Generic clearance is requested to ensure that timely information
is collected during a DORI, which allows NCIPC to maintain critical
mission function by working with state and local health authorities to
protect the public's health. During an unanticipated rise in nonfatal
or fatal drug overdose where the substances responsible for the health
event need to be identified, drivers and risk factors are undetermined,
and/or subgroups at risk need to be identified, immediate action by CDC
is necessary to minimize or prevent public harm. CDC must have the
ability to rapidly deploy data collection tools to understand the scope
of the problem and determine appropriate action. Procedures for each
investigation, including specific data collection plans, depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand. Data are
collected by epidemiologists, psychologists, medical professionals,
subject matter experts, and biostatisticians.
Data collected during a DORI are used to understand sudden
increases in drug use and misuse associated with fatal and nonfatal
overdoses, understand the drivers and risk factors associated with
those trends, and identify the groups most affected. This allows CDC to
effectively advise states on actions that could be taken to control the
local epidemic. During a DORI, data are collected once, with the rare
need for follow-up. The estimated annual burden hours are 1,500, there
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response DORI Data 3,000 1 30/60 1,500
Investigation Participants. Collection
Instruments.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-17710 Filed 8-12-20; 8:45 am]
BILLING CODE 4163-19-P